Early Clinical Improvement as Predictor of Long-Term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated With Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study

被引：0
|
作者：
McInnes, Iain [1 ]
Soriano, Enrique [2 ,3 ]
Tam, Lai-Shan
Bessette, Louis [4 ,5 ]
Shiff, Natalie [6 ]
Shawi, May [7 ]
Rampakakis, Emmanouil [8 ]
Curtis, Jeffrey [9 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Inst Univ, Hosp Italiano Buenos Aires, Dept Publ Hlth, Escuela Med, Buenos Aires, DF, Argentina
[3] Hosp Italiano Buenos Aires, Rheumatol Unit, Internal Med Serv, Buenos Aires, DF, Argentina
[4] Univ Laval, Laval, PQ, Canada
[5] CHU Quebec, Laval, PQ, Canada
[6] Univ Florida, Gainesville, FL USA
[7] Janssen Inc, Raritan, NJ USA
[8] JSS Med Res Inc, Montreal, PQ, Canada
[9] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF RHEUMATOLOGY | 2023年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
88
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [21] Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab
    Quartuccio, L.
    Schiavon, F.
    Zuliani, F.
    Carraro, V.
    Catarsi, E.
    Tavoni, A.
    Bombardieri, S.
    Punzi, L.
    De Vita, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (06) : 922 - 928
  • [22] Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with Ulcerative Colitis: A post hoc analysis of the SELECTION and SELECTION long-term extension trials
    Matsuoka, K.
    Schreiber, S.
    Hata, E.
    Kaise, T.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1368 - i1370
  • [23] Long-term health-related quality of life in patients treated for localized prostate cancer
    Punnen, Sanoj
    Cowan, Janet E.
    Carroll, Peter
    Cooperberg, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [24] Long-term Safety of Guselkumab (TREMFYA®) in Patients with Active Psoriatic Arthritis: Pooled Results from 3 Randomized Clinical Trials Through up to 2 Years
    Rahman, Proton
    Ritchlin, Christopher
    Mease, Philip
    Helliwell, Philip S.
    Boehncke, Wolf-Henning
    McInnes, Iain
    Shawi, May
    Marrache, Anne Marilise
    Kollmeier, Alexa
    Xu, Xie
    Yu, Jenny
    Wang, Yanli
    Sheng, Shihong
    Gottlieb, Alice
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3757 - 3759
  • [25] Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-na_ive Patients With Psoriatic Arthritis (PsA)
    Gladman, Dafna D.
    Starr, Michael
    Ranza, Roberto
    Bravo, Ana-Maria
    Strauss, Marcie
    Shawi, May
    Han, Chenglong
    Rampakakis, Emmanouil
    Ostor, Andrew
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB189 - AB189
  • [26] The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies
    Kavanaugh, Arthur
    Gottlieb, Alice
    Morita, Akimichi
    Merola, Joseph F.
    Lin, Chen-Yen
    Birt, Julie
    Shuler, Catherine L.
    Hufford, Matthew M.
    Thaci, Diamant
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (09) : 1215 - 1219
  • [27] Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
    Bruce Strober
    Laura C. Coates
    Mark G. Lebwohl
    Atul Deodhar
    Evan Leibowitz
    Katelyn Rowland
    Alexa P. Kollmeier
    Megan Miller
    Yanli Wang
    Shu Li
    Soumya D. Chakravarty
    Daphne Chan
    May Shawi
    Ya-Wen Yang
    Diamant Thaҫi
    Proton Rahman
    Drug Safety, 2024, 47 : 39 - 57
  • [28] Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
    Strober, Bruce
    Coates, Laura C.
    Lebwohl, Mark G.
    Deodhar, Atul
    Leibowitz, Evan
    Rowland, Katelyn
    Kollmeier, Alexa P.
    Miller, Megan
    Wang, Yanli
    Li, Shu
    Chakravarty, Soumya D.
    Chan, Daphne
    Shawi, May
    Yang, Ya-Wen
    Thaci, Diamant
    Rahman, Proton
    DRUG SAFETY, 2024, 47 (01) : 39 - 57
  • [29] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    RMD OPEN, 2023, 9 (01):
  • [30] Long-term health-related quality of life in patients with ruptured arteriovenous malformations treated in childhood
    Oulasvirta, Elias
    Pohjola, Anni
    Koroknay-Pal, Paivi
    Hafez, Ahmad
    Roine, Risto
    Sintonen, Harri
    Laakso, Aki
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2022, 30 (03) : 292 - 300
12345